Surgical decision–making in borderline resectable pancreatic cancer in the era of neoadjuvant therapy: from response assessment to individualized operative strategy

Lei Zhu, Hongbin Han, Gang Liu, Haichun Zhao, Mengxin Luo

Open source

DOI
10.3389/fsurg.2026.1935508
Published
2026-09-08
Container
Frontiers in Surgery
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fsurg.2026.1935508,
  title = {Surgical decision–making in borderline resectable pancreatic cancer in the era of neoadjuvant therapy: from response assessment to individualized operative strategy},
  author = {Lei Zhu and Hongbin Han and Gang Liu and Haichun Zhao and Mengxin Luo},
  year = {2026},
  journal = {Frontiers in Surgery},
  doi = {10.3389/fsurg.2026.1935508},
  url = {https://doi.org/10.3389/fsurg.2026.1935508}
}

RIS

TY  - JOUR
TI  - Surgical decision–making in borderline resectable pancreatic cancer in the era of neoadjuvant therapy: from response assessment to individualized operative strategy
AU  - Lei Zhu
AU  - Hongbin Han
AU  - Gang Liu
AU  - Haichun Zhao
AU  - Mengxin Luo
PY  - 2026
JO  - Frontiers in Surgery
DO  - 10.3389/fsurg.2026.1935508
UR  - https://doi.org/10.3389/fsurg.2026.1935508
ER  - 

APA

Zhu, L., Han, H., Liu, G., Zhao, H., & Luo, M. (2026). Surgical decision–making in borderline resectable pancreatic cancer in the era of neoadjuvant therapy: from response assessment to individualized operative strategy. Frontiers in Surgery. https://doi.org/10.3389/fsurg.2026.1935508

Source records